Faster excursion detection improves supply visibility but also exposes an often-overlooked gap: a deviation plan outlining who has authority and what actions to take.
- Clinical Pharmacy-Led Perspective On Clinical Trial Supply Innovation
- Inside GCSG 2026: Clinical Supply Impact On Patient Experience
- U.S. Policy Drift And The Shift In Clinical Trial Supply Leadership
- The Hidden Operational Complexities Of Home Infusion
- Building Resilient Clinical Trial Supply Chains In An Era Of Geopolitical Risk
- Site-Level Execution In Clinical Trials: Where Systems Break Down
- Blind Spots And Blocked Ports: Surviving Clinical Supply Friction In LATAM And APAC
- Truth: Clinical Supply Is Often The First To See The Whole Picture
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Enhancing Clinical Supply Chain With Signant SmartSignals Supplies
A global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.
-
Overcoming Challenges In Cell And Gene Therapy Containment
Review the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.
-
Specializing In Small And Early-Stage Partners, Not Just Small Batches
Many small and/or early-stage companies are not aware of the need, or the possibility, of finding a CDMO that specializes in meeting their specific requirements.
-
Benefits Of Electronic Labels: Investigational Medicinal Products
When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
-
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization
While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
From Frustration To Organization: An SSO Platform For Trial Sites
To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.
-
24/7 Cell & Gene Control Tower Provides Agile Solution For Critical Shipments
Get an overview of a successful re-route of six critical shipments to the UK and Spain from Amsterdam used to deliver CAR-T drug products to treat non-Hodgkin’s lymphoma cancer patients.
-
Quality Assured: Bringing Life-Changing Therapies To Patients
Biopharmaceutical drug development remains a key trend, demanding specific expertise and capabilities when it comes to quality assurance. Explore four trends that matter in biologics for clinical trial supply.
-
Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It
Protecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.
-
Is Your Clinical Supply Strategy Ready For EU CTR?
One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.